secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001493152-23-042670
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma to repurchase 145K shares from Bios Entities at $3.44/share
--------------------------------------------------------------------------

- Company agreed to buy 145,348 common shares from Bios Fund I entities at $3.44/share, total ~$500K.
- Bios Entities own ~14.7% of outstanding shares; sale for their own working capital and liquidity.
- Transaction expected to close by November 30, 2023; customary reps, warranties, and covenants.
- Buyback represents about 0.5% of shares outstanding (based on recent filings).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/0001493152-23-042670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer